Clincosm LogoSign in Get a demo

cardiometabolic syndrome

Showing 26 - 35 of 35
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cardiometabolic Syndrome, Weight Loss Trial in Winnipeg (Lifestyle program)

Active, not recruiting
  • Cardiometabolic Syndrome
  • Weight Loss
  • Lifestyle program
  • Winnipeg, Manitoba, Canada
    Chronic Disease Innovation Centre, Seven Oaks Hospital
Apr 21, 2022

Adolescent Obesity, Life Style, Healthy, Body Weight Changes Trial in Prague (lifestyle education)

Recruiting
  • Adolescent Obesity
  • +3 more
  • lifestyle education
  • Prague, Czechia
    Faculty Hospital Kralovske Vinohrady
Apr 24, 2022

COVID-19, Aging, and Cardiometabolic Risk Factors Study

Active, not recruiting
  • Covid19
  • +5 more
    • Jakarta Pusat, DKI Jakarta, Indonesia
    • +1 more
    Apr 11, 2022

    Time Restricted Feeding, Obesity, Abdominal, Cardiometabolic Syndrome Trial in Pamplona, Granada (Early time-restricted eating,

    Recruiting
    • Time Restricted Feeding
    • +2 more
    • Early time-restricted eating
    • +2 more
    • Pamplona, Navarra, Spain
    • +1 more
    Mar 25, 2022

    Network Meta-analysis of Intermittent Fasting and

    Active, not recruiting
    • Obesity
    • +10 more
    • Intermittent Fasting
    • Toronto, Ontario, Canada
    • +1 more
    Mar 24, 2022

    Cardiometabolic Syndrome Trial in Preston (Nutrition knowledge)

    Completed
    • Cardiometabolic Syndrome
    • Nutrition knowledge
    • Preston, Lancashire, United Kingdom
      University of Central Lancashire
    Jan 5, 2022

    Cardiometabolic Syndrome Trial in San Francisco (Educational Materials and Chronic Disease Management Test (CDMT))

    Recruiting
    • Cardiometabolic Syndrome
    • Educational Materials and Chronic Disease Management Test (CDMT)
    • San Francisco, California
      QURE Healthcare
    Dec 30, 2021

    Inflammation and Obesity-associated Disease

    Recruiting
    • Obesity
    • +6 more
    • Laparoscopic surgery
    • Gothenburg, Sweden
      Sahglrenska University Hospital
    Oct 14, 2021

    Cardiometabolic Syndrome Trial in Malang (ß-1,3/1,6-D-Glucan From Mycelia Extract of Indonesia's Ganoderma Lucidum Group,

    Enrolling by invitation
    • Cardiometabolic Syndrome
    • β-1,3/1,6-D-Glucan From Mycelia Extract of Indonesia's Ganoderma Lucidum Group
    • Placebo Group
    • Malang, East Java, Indonesia
      General Hospital of Brawijaya University (Rumah Sakit Universita
    Oct 3, 2021

    Psoriasis, Inflammation, Coronary Artery Disease Trial in United States (Orticumab, Placebo)

    Recruiting
    • Psoriasis
    • +3 more
    • Scottsdale, Arizona
    • +12 more
    Jul 29, 2021